Skip to main content
OpenTrials

Clinical trial condition

Digestive System Neoplasms

Explore clinical trials studying Digestive System Neoplasms. Study availability and eligibility vary by location and protocol.

14,195 public trials 3,223 recruiting studies
Refine in advanced search Browse all conditions

Digestive System Neoplasms trial results

Recruiting

Symbiotic-GI-16: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Gastroesophageal Cancer

NCT07392892

Conditions
Adenocarcinoma Of Esophagus, Digestive System Diseases, Digestive System Neoplasms, +10 more
Locations
  • Rocky Mountain Cancer Centers, LLP Aurora, Colorado, United States
  • Rocky Mountain Cancer Centers, LLP Boulder, Colorado, United States
  • Rocky Mountain Cancer Centers, LLP Centennial, Colorado, United States
  • Rocky Mountain Cancer Centers, LLP Colorado Springs, Colorado, United States
View all 70 locations
View Trial Details
Recruiting

Testing the Addition of a New Anti-cancer Drug, M3814 (Peposertib), to the Usual Radiotherapy in Patients With Locally Advanced Pancreatic Cancer

NCT04172532

Conditions
Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +7 more
Locations
  • City of Hope Comprehensive Cancer Center Duarte, California, United States
  • UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care Irvine, California, United States
  • City of Hope at Irvine Lennar Irvine, California, United States
  • UC Irvine Health/Chao Family Comprehensive Cancer Center Orange, California, United States
View all 44 locations
View Trial Details
Recruiting

Study of Patritumab Deruxtecan in Participants With Gastrointestinal Cancers (MK-1022-011) (HERTHENA-PanTumor02)

NCT06596694

Conditions
Digestive System Diseases, Digestive System Neoplasms, Gastrointestinal Cancer, +4 more
Locations
  • UCLA Hematology Oncology Santa Monica ( Site 1205) Santa Monica, California, United States
  • University of Colorado Cancer Center ( Site 1200) Aurora, Colorado, United States
  • Sibley Memorial Hospital ( Site 1208) Washington D.C., District of Columbia, United States
  • University of Florida ( Site 1202) Gainesville, Florida, United States
View all 62 locations
View Trial Details
Recruiting

Study of Sotorasib, Panitumumab and FOLFIRI Versus FOLFIRI With or Without Bevacizumab-awwb in Treatment-naïve Participants With Metastatic Colorectal Cancer With KRAS p.G12C Mutation

NCT06252649

Conditions
Colonic Diseases, Colorectal Neoplasms, Digestive System Diseases, +9 more
Locations
  • Ironwood Cancer and Research Centers Scottsdale Chandler, Arizona, United States
  • Providence Saint Jude Medical Center Fullerton, California, United States
  • City of Hope National Medical Center Long Beach, California, United States
  • Cancer and Blood Research Center, LLC Los Alamitos, California, United States
View all 291 locations
View Trial Details
Recruiting

AMG 410 Alone and in Combination With Other Agents in Participants With KRAS Altered Advanced or Metastatic Solid Tumors

NCT07094113

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +17 more
Locations
  • City of Hope National Medical Center Duarte, California, United States
  • University of California Los Angeles Los Angeles, California, United States
  • Emory University Atlanta, Georgia, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
View all 39 locations
View Trial Details
Recruiting

D07001 Softgel-Capsules and Capecitabine Combination Therapy in Patients With Advanced Biliary Tract Cancer

NCT06622057

Conditions
Adenocarcinoma, Biliary Tract Cancer (BTC), Biliary Tract Diseases, +9 more
Locations
  • Mount Sinai Medical Center Miami Beach, Florida, United States
  • University Hospital Cleveland Medical Center Cleveland, Ohio, United States
  • Kaohsiung Medical University Chung-Ho Memorial Hospital Kaohsiung City, Taiwan
  • The University of Arizona Cancer Center Tucson, Arizona, United States
View Trial Details
Recruiting

A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors

NCT04657068

Conditions
Acinar Cell Carcinoma, Adenocarcinoma, Adnexal Diseases, +55 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Mayo Clinic (Arizona) Scottsdale, Arizona, United States
  • University of Arkansas - Winthrop P. Rockefeller Cancer Institute Little Rock, Arkansas, United States
  • USC Norris Comprehensive Cancer Center Los Angeles, California, United States
View all 82 locations
View Trial Details

Related conditions